GGPS1 and muscular dystrophy: While monoallelic variants in GGPS1 have been identified as a risk factor for atypical femoral bone fractures in females exposed to bisphosphonates, ultra‐rare biallelic pathogenic missense variants in GGPS1 have recently been associated with muscular dystrophy/hearing loss/ovarian insufficiency syndrome.2, 3